MAP2K1 and melanoma: In a genome-wide sequencing study of 183 melanomas, Hayward et al. reported five cases with MAP2K1 mutations, all defined as missense in supplemental materials, and all co-occurring with either BRAF, NRAS, or NF1 mutations [4].